Skip to main content

Table 2 Distribution of types of aneuploidies

From: Embryos derived from donor or patient oocytes are not different for in vitro fertilization outcomes when PGT allows euploid embryo selection: a retrospective study

 

Patient/donor oocytes

Patient oocytes

Donor oocytes

Age range

≥ 18

≥ 18

≤ 29

18–32

Total embryos

3038

2186

172

852

Abnormal embryos

1351 (44.5%)

1113 (50.9%)

46 (26.7%)

238 (27.9%)

Monosomy

381 (28.2%)

283 (25.4%)

15 (32.6%)

98 (41.2%)*

Trisomy

346 (25.6%)

282 (25.3%)

13 (28.3%)

64 (26.9%)

Dual

302 (22.4%)

266 (23.9%)

11 (23.9%)

36 (15.1%)*

Multiple

322 (23.8%)a

282 (25.3%)b

7 (15.2%)c

40 (16.8%)d,*

  1. *Indicates a significant difference (p < 0.05, chi-2 test) in the rate of chromosome abnormalities between embryos from patient oocytes and donor oocytes. ** indicates a significant difference (p < 0.05, chi-2 test) in the rate of chromosome abnormalities between embryos from patient oocytes and donor oocytes
  2. aTwenty-six embryos had completely abnormal chromosomal profiles
  3. bTwenty-two embryos had completely abnormal chromosomal profiles
  4. cZero embryos had completely abnormal chromosomal profiles
  5. dFour embryos had completely abnormal chromosomal profiles